ThinkSabio

$NKTX

$1.78▲ +1.7% YTD

4 SEC 13D/G filings tracked · Last updated Nov 9, 2026

Filing History
News
NKTX ▲ +1.7% - Nkarta, Inc.
CP $1.78▲ +1.7%Nov 9, 2026 · ThinkSabio Blog

$NKTX - Nkarta Announces Initial Clinical Data for NKX019 in Myositis and Systemic Sclerosis at ACR Convergence…

News
NKTX ▲ +10.8% - Nkarta, Inc.
CP $1.75▲ +10.8%Nov 6, 2026 · ThinkSabio Blog

$NKTX - Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026…

News
NKTX ▼ -9.2% - Nkarta, Inc.
CP $1.57▲ -9.2%Nov 5, 2026 · ThinkSabio Blog

$NKTX - Nkarta Reports Third Quarter 2026 Financial Results and Provides Business Update…

News
NKTX ▼ -0.7% - Nkarta, Inc.
CP $2.90▲ -0.7%Sep 8, 2026 · ThinkSabio Blog

$NKTX - Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026…